We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Laboratory Medicine and Nosocomial Infections: Surveying HIAs

By LabMedica International staff writers
Posted on 22 Feb 2010
Seventh article in Laboratory Medicine and Nosocomial Infections series - In January 2009, the US Department of Health and Human Services (Washington DC, USA) established a set of five-year national prevention targets to reduce and possibly eliminate healthcare-associated infections (HIAs). More...
Two consortiums were formed in 2008 to establish connections between hospital labs and leading academic labs to track drug-resistant patterns and new multiple antibiotic-resistant strains.

The results of one International Nosocomial Infection Control Consortium (INICC) surveillance study from 2002 through 2007 in 98 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe were reported in the November 2008 American Journal of Infection Control (AJIC) by Victor D. Rosenthal, M.D., M.Sc., CIC, International Nosocomial Infection Control Consortium (INICC; Buenos Aires, Argentina).

Prospective data from 43,114 patients hospitalized in the Consortium's hospital ICUs for an aggregate of 272,279 days were collected. The pooled rate of central line-associated bloodstream infections (CLABs) in the INICC ICUs was nearly 3-fold higher than reported from comparable U.S. ICUs and the overall rate of ventilator-associated pneumonia was far higher, as was the rate of catheter-associated urinary tract infection. The frequencies of resistance of Staphylococcus aureus isolates to methicillin (MRSA), Enterobacter species to ceftriaxone, and Pseudomonas aeruginosa to fluoroquinolones were also far higher in the consortium's ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 14.3% to 27.5% (ventilator-associated pneumonia).

Related Links:
US Department of Health and Human Services
International Nosocomial Infection Control Consortium


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image

Bioluminescent Molecular Diagnostics Platform Enables Rapid On-Site Pathogen Detection

Infectious diseases such as malaria, gonorrhea, and chlamydia continue to pose serious global health challenges, particularly in low-income countries with limited healthcare infrastructure.... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.